Giobal Convergence • Defining Standards – The Grand Opening of Singclean International Medical Aesthetic Leaders Summit

Figure 1: Singclean GALA NIGHT

On July 12, 2025, the 1st International Medical Aesthetic Leaders Summit was grandly held at the Jin Mao Tower in Shanghai. Under the theme "Giobal Convergence·Defining Standards", the summit brought together leading global players, including BD (Becton Dickinson), the world’s leading manufacturer of prefilled syringes, and France’s HTL, a top developer and supplier of biomedical polymers for aesthetic medicine. Industry leaders and experts from multiple countries gathered to discuss the construction and upgrading of the quality ecosystem in the aesthetic medicine industry. Initiated by Singclean Medical, this landmark event signifies Singclean Medical’s further advancement in global strategic cooperation, joining hands with partners across the industry chain to drive the aesthetic medicine industry into a new stage of high-quality development.

Figure 2: Launch Ceremony of the 2025 Singclean International Medical Aesthetic Leaders Summit

Chinese and International Aesthetic Medicine Leaders Jointly Launch the “Quality Initiative”，building an Artisan-Level Ecosystem

At the summit, Sun Weiqing, CEO of Singclean Medical, together industry leaders: Yao Kaihua, CEO of Guangxi Angyu Biotechnology Co., Ltd.; He Shen, CEO of Hangzhou Baixin Medical Devices Co., Ltd.; Dong Shiyong, Founder of Youmei Medical; Liu Dong, Executive President of Chongshan Biotech.

Mr. He Shen has been deeply engaged in the medical device industry for many years. With exceptional market insight and efficient channel management, his team has successfully made “Singfiller” the top-selling brand in China for two consecutive years.

Mr. Yao Kaihua, a rising star in the industry, achieve a phenomenal sales record of 1 million syringes within just one year, thanks to a strong partnership with Singclean’s international-standard OEM services.

Mr. Liu Dong has led Chongshan Biotech to achieve billions in sales within just three years, building a strong and efficient direct sales network of over 300 frontline representatives. Since establishing a strategic partnership with Singclean at the end of last year, total sales have already approached 300,000 syringes.

Jiang Wei, Vice President of BD Pharmaceutical Systems China; Huang Zhe, Head of HTL China Business; Mr. Polachai, CEO of Thailand’s Pola Group; Mr. Khaled, Founder of Arabian Medical (UAE); and Ms. Bundova, CEO of Russia’s FARM BSK, jointly announced the official launch of the Aesthetic Medicine Industrial Quality Cooperation Initiative.

With “Craftsmanship and Quality” at its core, this initiative integrates the collaborative strength of the global supply chain, brand owners, and academic institutions. It not only solidifies a shared consensus on high-quality industry development but also sets a clear direction for innovative cooperation. This landmark event injects a well-defined development roadmap and powerful momentum for industry transformation, allowing China’s intelligent manufacturing to shine ever brighter on the global aesthetic medicine stage.

Figure 3: Strategic Signing Ceremony – Russia’s Farm BSK, Thailand’s Pola Group, and Youmei Medical

Deepening the Quality Strategy to Build a Foundation of Trust in the Aesthetic Industry

At the summit, the strategic signing ceremony between Singclean Medical and its key partners became a major highlight, marking a significant milestone in dual cooperation and demonstrating the company’s strong commitment to global expansion. Upholding its "Quality First" development philosophy, Singclean Medical pursues excellence in every stage of product research, development, and manufacturing. Guided by the core strategy of "Service Value Over Product Value", the company empowers the entire industry chain to create more competitive, high-quality products, achieving mutual benefits with partners and providing safer, more reliable products for beauty seekers.

During the highly anticipated keynote speech, “The Quality Pyramid: From Strategic Advisor to Preferred Partner,” Mr. Dong Shiyong, founder of Youmei Medical, shared his journey of cooperation with Singclean Medical. He emphasized that Singclean’s rigorous standards — from raw material sourcing and production processes to strict quality control — fully embody the corporate spirit of "Caution Means Responsibility." This relentless pursuit of quality has not only earned Singclean widespread market recognition but has also transformed Youmei Medical from an initial brand consultant into a deep strategic partner, vividly illustrating the belief that “Quality is the strongest foundation for cooperation.”

Figure 4: Dr. Liu Linlin’s Injection Presentation at IMCAS

Academic Talk on Quality: Reshaping Native Facial Aesthetics with High-Viscoelastic Sodium Hyaluronate

At the concurrent IMCAS China Conference, Dr. Liu Linlin’s academic lecture on injection techniques drew significant attention. With profound expertise, she elaborated on her innovative aesthetic concept, the “Three-Part Injection & Seven-Part Care x Viscoelastic HA filler: Redefning Native Facial Aesthetics” She meticulously dissected her self-developed injection methodology, demonstrating how the precise application of Singclean’s high-viscoelastic sodium hyaluronate can naturally redefine native facial contours, achieving the sought-after “born-with-it beauty” effect and ensuring a naturally radiant appearance from the inside out.

Following her talk, Dr. Liu confidently addressed in-depth questions from Hugues Cartier, IMCAS Co-Chairman and Chief Scientific Officer (CSO), and engaged enthusiastically with the audience. Her dedication to academic rigor and deep clinical insight vividly showcased the unique charm of “pursuing academic excellence to the utmost” in aesthetic medicine, setting a benchmark where quality and professionalism go hand in hand.

From regional leadership to global recognition, from product innovation to standard-setting, the pursuit of beauty is deeply rooted in a solid quality system. On this expansive journey, Singclean  Medical’s collaboration with its partners is undoubtedly one of the most compelling chapters, destined to leave an extraordinary mark on the global aesthetic medicine landscape.

Figure 5: Group Photo at the SINGCLEAN GALA Dinner

The Future is Here: Singclean Medical Leading with Innovation and Global Cooperation

Looking ahead, Singclean Medical will continue to maintain a forward-thinking approach in technological research and development, while deepening mutual trust and win-win cooperation globally. Every pursuit of beauty will be firmly rooted in a solid quality system, ensuring reliability and excellence.

From regional leadership to global recognition, from product innovation to standard-setting, this vast journey across continents will undoubtedly leave an extraordinary mark on the aesthetic medicine industry. Among all these milestones, Singclean Medical’s shared journey with its partners will remain one of the most inspiring chapters in this brilliant story.